Darbepoetin Alpha in Myelodysplastic Syndromes (MDS)

Clinical trial NCT00443339 · UNKNOWN

Trial details

NCT number: NCT00443339
Sponsor: Groupe Francophone des Myelodysplasies
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes

Start date: 2006-12-01
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.